- 17 июн
- 18 июн
- 28 июн
- 29 июн
- 30 декабр
Хатҳои шартбандӣ дар Тиб
Рӯйдодҳои машҳур ва хабарҳои варзиш
Line
- FDA to approve GSK & Spero Therapeutics' Tebipenem HBr
- FDA to approve Ionis' Olezarsen
- FDA to approve Arcutis' Zoryve cream
- FDA to approve Arcalyst technology transfer
- FDA approves Retatrutide this year?
- FDA to approve Viridian Therapeutics' Veligrotug
- CDC to issue Level 4 warning by December 31
- FDA to approve Merck's Welireg + Keytruda or Keytruda Qlex
- FDA to approve Unicycive's Oxylanthanum carbonate